Skip to main content

Resources

A number of resources are available from around the world to help inform and educate health practitioners, patients and families about pre-eclampsia and other hypertension-related conditions in pregnancy. We will continue to build a list of these resources over time.

World Health Organization 

The World Health Organization provides guidelines for maternal health in low-resourced settings:

Global Library of Women's Medicines (GLOWM)

A detailed presentation on pre-eclampsia and eclampsia by Dr Peter von Dadelszen

 

GLOWM has published The FIGO Textbook of Pregnancy Hypertension. The aim of the textbook is to offer globally-relevant and robust evidence-based guidance for monitoring, prevention and treatment of hypertensive disorders of pregnancy. The book was made possible with generous support from the Sabrina’s Foundation, and David and Paula Bloomer from GLOWM.

The USAID MCHIP (Maternal and Child Health Integrated Program) 

MCHIP provides information on pre-eclampsia and eclampsia targeted to low-resourced settings along with a tool-kit for LMIC providers.

Ending Eclampsia

Ending Eclampsia is a global coalition that seeks to expand access to proven, underutilized interventions and commodities for the prevention, early detection, and treatment of pre-eclampsia and eclampsia, and seeks to strengthen global partnerships. To achieve these goals, Ending Eclampsia is comprised of researchers, programmers, midwives and clinicians, joining forces to reduce maternal mortality due to pre-eclampsia and eclampsia. Through this network, members will generate and share best practices and strategies to screen, diagnose, and manage pre-eclampsia and eclampsia.

  • To be a part of the coalition sign up here

American College of Obstetricians and Gynecologists

The American College of Obstetricians and Gynecologists (The College), based in the United States of America, strongly advocates for quality health care for women, maintains the highest standards of clinical practice and continuing education of its members, promotes patient education, and increases awareness among its members and the public of the changing issues facing women’s health care. 

CRADLE Trial 

The aims of the CRADLE project are to develop a device capable of accurately detecting abnormalities in vital signs (including blood pressure (BP) and heart rate (HR)) and to introduce this device to LMICs communities and hospitals. CRADLE also aimsto prospectively evaluate the device’s ability to facilitate prompt referral and intervention, with the aim of reducing mortality and morbidity.They aim to improve global women’s health through innovative research.